BPTS Biophytis SA ADRs

Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ALBPS.

$6.93
As of 10/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  
IPO date:  02/10/2021
Outstanding shares:  12,075,924
Average volume:  1,784
Market cap:   $83,683,738
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   9.85
PS ratio:   0.00
Return on equity:   -274.08%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy